French Bioscience Biz Raises €3M For New Drug Trials
NFL Biosciences said Friday it had successfully raised approximately €3.1 million ($3.3 million) by issuing shares to investors to raise cash for new drug trials....To view the full article, register now.
Already a subscriber? Click here to view full article